Advancing Diagnostics Through Innovative Technologies.

Thank you for connecting with Waters at MSACL 2026 in Montreal.

This year marked an exciting milestone as we demonstrated how our portfolio, scientific expertise, and innovative technologies can help laboratories improve efficiency, enhance diagnostic confidence, and advance patient care. 

Whether you visited our booth, attended one of our educational events, met with our experts, or were unable to join us in Montreal, we invite you to continue exploring the latest innovations from Waters. 

 

Explore our MSACL 2026 Highlights

Attendees experienced innovative technologies and solutions including:

The New Xevo TQ Absolute XR IVD Mass Spectrometer

Greater Confidence. Exceptional Performance. Designed for the Clinical Laboratory.

MSACL attendees were among the first to experience the Xevo TQ Absolute XR IVD Mass Spectrometer (MS)—designed to help clinical laboratories meet evolving testing demands with exceptional analytical sensitivity, enhanced robustness, and greater operational efficiency.

Powered by StepWave™ XR Ion Guide Technology, the Xevo TQ Absolute XR IVD MS delivers the analytical performance and long-term reliability needed to confidently expand clinical LC-MS/MS testing while helping laboratories maximize productivity and optimize valuable laboratory space. 

Explore Our Diagnostics Solutions Portfolio

Discover LC-MS/MS solutions designed to support your laboratory’s evolving needs:

Advance analytical confidence and laboratory efficiency with the Xevo TQ Absolute XR IVD MS and our portfolio of clinical LC-MS/MS solutions, including:

  • Xevo TQD IVD Mass Spectrometer
  • ACQUITY™ UPLC™ I-Class PLUS IVD System
  • MassTrak™ Clinical Reagents
  • waters_connect™ Software Solutions

 

Thank You for Making MSACL 2026 a Success

Thank you to everyone who visited our booth, participated in our educational events, connected with our experts, and helped make MSACL 2026 a memorable experience. 

We look forward to continuing our collaboration and working together to advance the future of diagnostics.